Andere talen InDex Pharmaceuticals Holding AB

Aandelen

INDEX

SE0008966295

Vertraagde tijd Nasdaq Stockholm Andere beurzen 10:48:32 24-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,357 ^SEK	+2,59%		+9,51%	+39,45%

05/04	InDex Pharmaceuticals Holding AB (Publ) kondigt ontslag van de Raad van Bestuur aan	CI
26/03	CEO en CFO van InDex Pharmaceuticals stappen op wegens stopzetting van activiteiten	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

InDex Pharmaceuticals brings forward the publication of the interim report for Q1 2024	22/04
InDex Pharmaceuticals provides a company update	08/04
InDex Pharmaceuticals Holding AB (publ) publishes Annual Report for 2023	08/04
Notice of Annual General Meeting in InDex Pharmaceuticals Holding AB (publ)	05/04
Index Pharmaceuticals Holding AB Announces Board Resignations	05/04
InDex Pharmaceuticals CEO, CFO to Step Down as Operations Cease	26/03
CEO and CFO both to leave InDex Pharmaceuticals	26/03
Index Pharmaceuticals Holding AB Announces Resignation of Johan Giléus as Deputy CEO	26/03
InDex Pharmaceuticals Holding AB Announces Resignation of Jenny Sundqvist as CEO, Effective September 26, 2024	26/03
InDex Pharmaceuticals Holding AB Announce Resignation of Johan Giléus as CFO, Effective September 26, 2024	26/03
InDex Pharmaceuticals Launches Strategic Review Amid Decision to Stop Cobitolimod Development	27/02
InDex Pharmaceuticals provides an update on company's future	26/02
InDex Pharmaceuticals discontinues the development of cobitolimod	26/02
InDex Pharmaceuticals Holding AB Discontinues the Development of Cobitolimod	26/02
InDex Pharmaceuticals Holding AB (publ) year-end report 2023	21/02
InDex Pharmaceuticals Holding AB Reports Earnings Results for the Full Year Ended December 31, 2023	21/02
InDex Pharmaceuticals Holding AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	21/02
InDex Pharmaceuticals announces expected cash balance per March 31, 2024	19/01
InDex Pharmaceuticals Holding AB interim report January-September 2023	29/11
InDex Pharmaceuticals Q3 2023 - Uncertain future post discontinuation of CONCLUDE	29/11

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen InDex Pharmaceuticals Holding AB

Aandelen

INDEX

SE0008966295

Andere talen

Filters